Process for the preparation of 1,4,7,10-tetraazacyclododecane

Details Process for the preparation of 1,4,7,10-tetraazacyclododecane Process for the preparation of 1,4,7,10-tetraazacyclododecane

2001-10-11

2003-11-25

Berch, Mark L. (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

C544S343000, C544S346000

Reexamination Certificate

active

06653470

ABSTRACT:

The present invention relates to a novel process for the preparation of 1,4,7,1-tetraazacyclododecane (I) comprising the steps represented in Scheme 1.
More precisely, the present invention relates to a process for the preparation of 1,4,7,10-tetraazacyclododecane (commnonly named Cyclen) alternative to the classical Richman-Atkins synthesis (see for example J. Am. Chem, Soc., 96, 2268, 1974), at present industrially used for the production of compound (I) in the form of the sulfate salt.
1,4,7,10-Tetraazacyclododecane is the precursor for the synthesis of macrocyclic chelating agents for metal ions, as these chelating agents form very stable complexes with such ions.
In particular, the complexes with the paramagnetic metal ions, specifically the gadolinium ion, of said chelaing agents can be used in the medical diagnostic field through Nuclear Magnetic Resonance technique, otherwise troublesome due to the high toxicity of the free ion.
At present, two contrast media are commercially available, namely Dotarem
(R)
and Prohance
(R)
, two gadolinium complexes the chemical structure of which is based on Cyclen, while others are still under investigation.
Therefore, it is important to work out a synthetic process for the preparation of said “building block”, which is cost-saving and industrially advantageous.
The process for the preparation of compound (I) should, therefore, be advantageous both from an economical and environmental point of view, avoiding the preparation of amine tosyl derivatives, commonly used in the conventional Richman-Atkins synthesis.
WO 97/49691 discloses the preparation of compound (I) by means of the steps represented in Scheme 2, in which compound of formula (III), decahydro-2a,4a,6a,8a-tetraazacyclopent[fg]acenaphthylene is the key intermediate for the formation of compound (I), and is obtainable by cyclization of the intermediate (IV), 3H,6H-octahydro-2a,5,6,8a-tetraazacenaphthylene, in its turn prepared from triethylenetetramine and glyoxal;
In order to cleave the two carbon atom-bridge which characterizes compound (III), therefore to obtain (I), an oxidizing process has been described which allows to transform (III) into oxidation products which can subsequently be hydrolysed and transformed into (I) by basic hydrolysis.
Alternatively to the oxidative cleavage, WO96/28432 suggests the direct hydrolysis of (III) with hydrobromic acid, or with hydroxylamine in ethanol solution under reflux.
On the other hand, Italian patent application MI 97A 000982, in the Applicant's name, disclosed a convenient process for the preparation of (I) starting from (III), alternative to the above one, comprising a hydrolysis step in aqueous solution, at slightly acidic, neutral or slightly basic pH, with a primary diamine of formula (VI), represented in the following Scheme 3:
in which x ranges from 0 to 2 and Q is —CH
2
CH(OH)CH
2
—, —(CH
2
)
2
NH(CH
2
)
2
— or —[(CH
2
)
2
NH]
2
(CH
2
)
2
when x is 1 or Q is —CH
2
— when x is 2.
Diethylenetriamine (DETA) is particularly preferred.
The reaction takes place in water, at a pH range from 5.5 to 9, preferably from 6 to 8, at temperatures from 60 to 100° C., in the presence of 2-20 mol of diamine per mol of (III), under inert gas atmosphere or in the air, for 12-48 h.
After completion of the reaction, the solution is alkalinized with a base, such as sodium hydroxide, concentrated to small volume or to a residue, and compound (I) is extracted with a suitable solvent, such as toluene, chloroform, butanol, amyl alcohol. The organic phase is concentrated to a residue, to obtain the crude macrocycle (I), which is finally recrystallized from toluene or ethyl acetate.
However, the advantages provided by the simple combination of the two processes according to the following
to obtain a valuable synthetic route to compound (I) are unsatisfactory, on the contrary unexpected technical problems arise, thus making their application on the factory scale difficult.
More particularly, isolation of compound (III) obtained by extraction with hexane, as described in WO 97/49691, leads to a loss of product during the concentration step of the reaction mixture, due partly to transport phenomena and partly to chemical degradation connected with the presence of parasitic alkylating agents.
In fact, as the cyclization reaction is preferential but not selective, the reaction between compound (IV) and 1,2-dichloroethane also gives rise to parasitic alkylating agents, as a consequence of side reactions of partial alkylation of said compound (IV), in amounts which cannot be ignored when operating on a large scale. These products are likely to react during the concentration step, thereby decreasing the yield in compound (III).
It has surprisingly been found that these problems can be overcome by isolating compound (III) in the form of a salt of a suitable inorganic acid.
Moreover, it has also been found that isolation of compound (I) from the reaction mixture in the form of the hydrochloride improves the industrial applicability of the process without affecting the overall yield in compound (I), as the liberation of the salt of compound (I) is quantitative.
It is therefore the object of the present invention a novel process for the preparation of compound (I) according to the following scheme 1:
which comprises the following steps:
a) condensation of triethylenetetramine (TETA) with glyoxal hydrate in water or water-soluble solvents or mixtures thereof, at a temperature ranging from 0 to 5° C., in the presence of stoichiometric amounts or of a slight excess of calcium hydroxide, to give the compound of formula (IV);
b) reaction of compound of formula (IV) with 1,2-dichloroethane, in amounts from 1 to 5 mol per mol of compound (IV), in dimethylacetamide (DMAC) and in the presence of Na
2
CO
3
, in amounts from 5 to 10 mol per mol of compound (IV), adding NaBr in amounts from 0.1 to 2 mol per mol of compound (IV) at a temperature from 25 to 150° C., to give the compound of formula (III) which is isolated in the form of a salt of an inorganic acid selected from the group consisting of hydrochloric acid and phosphoric acid;
c) hydrolysis of compound (III) by reaction with diethylenetriamine in water, at pH ranging from 5 to 9, at a temperature ranging from 90 to 120° C., in the presence of 5-10 mols of diethylenetriamine per mol of compound (III), under inert gas atmosphere or in the air, for 12-48 h, recovering compound (II) as the tetrahydrochloride; and optionally
d) quantitative liberation of the base to give compound of formula (I).
Step a) is substantially effected as described in WO 97/49691.
Step b) is also carried out according to the method described in WO 97/49691, but preferably following a modification as illustrated in the subsequent Italian application MI 97 A000783.
In particular, in the process of the present invention, condensation of compound (III) is carried out with 3-5 mols of 1,2-dichloroethane per mol of compound (III), in DMAC, in the presence of sodium carbonate, and with the addition of NaBr as a catalyst in amounts from 0.1 to 2 mol per mol of compound (III). The preferred conditions involve 3 mol of 1,2-dichloroethane, 10 mol of sodium carbonate, and the addition of 0.5 mol of NaBr.
It has unexpectedly been found, and it is object of the present invention, that after completion of the reaction and filtration of the inorganic salts, the above mentioned problems can be overcome by addition of an acid which is both soluble in dimethylacetamide and yields a salt of compound (III) insoluble in said dipolar aprotic solvent.
Hydrochloric acid and phosphoric acid proved to be particularly suitable for this purpose.
It has been found that, by using mixtures containing compound (III) suitably diluted with DMAC and adding an amount of 37% (w/w) HCl equivalent to 2-4 mol/mol of compound (IV), preferably 2,4 mol/mol, a precipitate forms containing about 95% of compound (III) present upon completion of the reaction.
A further improvement results by replacing 37% (w/w) HCl with 85% (w/w) H
3
PO
4
, which allows to

Affiliated with

Also associated with

Rating

Process for the preparation of 1,4,7,10-tetraazacyclododecane does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for the preparation of 1,4,7,10-tetraazacyclododecane, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of 1,4,7,10-tetraazacyclododecane will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3165237